NZMA Home

Table of contents
Current issue
Search journal
Archived issues
NZMJ Obituaries
Classifieds
Hotline (free ads)
How to subscribe
How to contribute
How to advertise
Contact Us
Copyright
Other journals
The New Zealand Medical Journal

 Journal of the New Zealand Medical Association, 26-July-2002, Vol 115 No 1158

Screening for type 2 diabetes
Tim Kenealey and colleagues’ excellent article on screening for type 2 diabetes gives good guidance to general practitioners and wisely leaves options open to initiate an early therapeutic opportunity1.
As advocated for more than twenty years an excellent chance to estimate residual beta cell reserve function is when the patient turns fifty years of age. They can then be advised to have a really very large three course mid day birthday dinner (possibly with other older brothers and sisters?). They present at the laboratory exactly two hours after the meal has been finished. This time suits most people and laboratories. Values returned over 7.0mmol/L will suggest beta cell reserves less than 30% rather than the more likely 50% expected in the average New Zealander.
An oral glucose tolerance test giving 2 hour values 7.8 – 11mmol/L will allow a diagnosis of impaired glucose tolerance, always a forerunner of diabetes and low levels of beta cell residual capacity. Two hour values over 11.0mmol/L on the OGTT make an “official” diagnosis of type 2 diabetes.1 In the United Kingdom there is usually a period of twelve years from onset to diagnosis.
Such two hour values relate much better to functioning residual beta cell mass, to future cardiovascular disease and to all cause mortality than do fasting blood glucose values alone – a late diagnostic feature.2-5
Diabetes NZ Inc, the Federation of thirty seven voluntary societies representing the 105 000 people with diabetes strongly supports earliest possible diagnosis set out in the Pricewaterhouse Coopers report of 2001.
Two other key issues emerge in respect to the widespread loss by midlife or earlier of non renewable beta cell function in so many people in New Zealand. It is now accepted that the earliest diagnosis is cost effective.6 Evidence for this has been reviewed.7 It is also now accepted8-10 that 150 minutes of active exercise weekly and four visits yearly for dietetic advice on weight management and reduction of saturated fat intake prevents diabetes. Our high New Zealand weight and animal fat levels were not designed for the beta cells or liver enzymes of our huntergather ancestors.
Five fold increases in animal fat ingestion increases insulin demand and often body mass index and, unless modified, accelerate B cell destruction.
This 50% prevention of progression to diabetes with the above lifestyle changes is exciting but a less well known finding of the last five years.
Let us all now initiate action and do something modern about diabetes in our country.
Sue Benny,
Diabetes Health Promoter.
Professor D W Beaven,
Prof Emeritus,
Diabetes Life Education and Patron Diabetes NZ,
Christchurch.

  1. Kenealey T, Braatvedt G, Scragg R. Screening for type 2 diabetes in non-pregnant adults in New Zealand: practice recommendations NZ Med J 2002; 115:194-6.
  2. Shaw JER, Hodge AN, de Courten M et al. Isolated postchallenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999; 42:1050-4.
  3. Decode Study Group. Glucose tolerance and mortality. Comparison of WHO and American Diabetes Assn. diagnostic criteria. Lancet 1999;354:617-21.
  4. Tominga M, Eguchi H, Manaka H et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study Care 1999: 220:920-4.
  5. Stagnavo S, West PJ, Hu FB et al. Diet and risk of type 2 diabetes. N Engl J Med 2002; 346:297-8.
  6. CDC Diabetes – Cost effectiveness study group. The cost-effectiveness of screening for type 2 diabetes. JAMA 1998; 280:1757-63.
  7. Beaven DW. Screening for diabetes. NZ Med J 199; 112:390.
  8. Tuomilehto J, Lindstrom J, Erikson JG et al. Prevention of type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343-50.
  9. Swinburn B, Metcalf P, Ley S. Longterm (5year) effect of a reduced fat intervention in individuals with glucose tolerance. Diabetes Care 2001; 24:619-24.
  10. Diabetes Prevention program. Diet and exercise dramatically delay type 2 diabetes: diabetes medication metformin also effective. www.niddk.nih.gov.

     
Current issue | Search journal | Archived issues | Classifieds | Hotline (free ads)
Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals